Journal of Clinical Endocrinology & Metabolism, Vol 70, 473-479, Copyright © 1990 by Endocrine Society

ARTICLES

Androgen-estrogen metabolism in women with upper body versus lower body obesity

MA Kirschner, E Samojlik, M Drejka, E Szmal, G Schneider and N Ertel
Metabolic and Nutrition Service, Newark Beth Israel Medical Center, New Jersey Medical School 07112.

Androgen and estrogen production rates were examined in 29 morbidly obese women with upper or lower body obesity. Although blood production rates of testosterone (T), dihydrotestosterone, and androstenedione (A4) were elevated in all of these women, those with upper body obesity (waist-height ratios, greater than 0.85) had higher T and production rates than women with lower body obesity (waist-height ratio less than 0.75). A4 was equally elevated in women with upper and lower body obesity. Peripheral aromatization of A4 to estrone (E1) averaged 1.67% in women with upper body obesity, but was elevated at 2.54% in women with lower body obesity. Urinary E1 production rates averaged 466 +/- 295 nmol/day (172 +/- 109 micrograms/day) in women with upper body obesity. Thus, women with lower body obesity had higher E1 production rates due entirely to increased peripheral aromatization. Women with upper body obesity were observed to have higher serum T and estradiol (E2) levels than women with lower body obesity. Further, upper body obesity was associated with decreased levels of sex hormone-binding globulin (16.1 +/- 5.7 nmol/L vs. 18.9 +/- 6.1 in women with lower body obesity). As a result, free T levels averaged 98.8 +/- 39.2 pmol/L in women with upper body obesity vs. 82.2 +/- 33 in women with lower body obesity. Similarly, serum free E2 levels were higher in women with upper body vs. lower body obesity. The data demonstrate that sex hormone production and metabolism are different in morbidly obese women with these differing phenotypes. Women with upper body obesity have higher androgen production rates and higher free T and free E2 levels, whereas women with lower body obesity make increased amounts of E1 from peripheral aromatization. The biological significance of increased aromatization may be offset by increased free E2 levels in women with upper body obesity.

This article has been cited by other articles:

				Y.-F. Tian, C.-H. Chu, M.-H. Wu, C.-L. Chang, T. Yang, Y.-C. Chou, G.-C. Hsu, C.-P. Yu, J.-C. Yu, and C.-A. Sun Anthropometric measures, plasma adiponectin, and breast cancer risk Endocr. Relat. Cancer, September 1, 2007; 14(3): 669 - 677. [Abstract] [Full Text] [PDF]

				A Trentham-Dietz, H. Nichols, J. Hampton, and P. Newcomb Weight change and risk of endometrial cancer Int. J. Epidemiol., February 1, 2006; 35(1): 151 - 158. [Abstract] [Full Text] [PDF]

				V. D. Yumuk and P. F. Yumuk What Links Obesity to Cancer? Indoor and Built Environment, December 1, 2005; 14(6): 527 - 532. [Abstract] [PDF]

				V. J Vieira, A. M Ronan, M. R Windt, and A. R Tagliaferro Elevated atopy in healthy obese women Am. J. Clinical Nutrition, September 1, 2005; 82(3): 504 - 509. [Abstract] [Full Text] [PDF]

				W. H. Xu, C. E. Matthews, Y. B. Xiang, W. Zheng, Z. X. Ruan, J. R. Cheng, Y. T. Gao, and X. O. Shu Effect of Adiposity and Fat Distribution on Endometrial Cancer Risk in Shanghai Women Am. J. Epidemiol., May 15, 2005; 161(10): 939 - 947. [Abstract] [Full Text] [PDF]

				S. M. van Anders and E. Hampson Waist-to-Hip Ratio Is Positively Associated With Bioavailable Testosterone but Negatively Associated With Sexual Desire in Healthy Premenopausal Women Psychosom Med, March 1, 2005; 67(2): 246 - 250. [Abstract] [Full Text] [PDF]

				A.-S. Furberg, G. Jasienska, N. Bjurstam, P. A. Torjesen, A. Emaus, S. F. Lipson, P. T. Ellison, and I. Thune Metabolic and Hormonal Profiles: HDL Cholesterol as a Plausible Biomarker of Breast Cancer Risk. The Norwegian EBBA Study Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 33 - 40. [Abstract] [Full Text] [PDF]

				A. McTiernan, K. B. Rajan, S. S. Tworoger, M. Irwin, L. Bernstein, R. Baumgartner, F. Gilliland, F. Z. Stanczyk, Y. Yasui, and R. Ballard-Barbash Adiposity and Sex Hormones in Postmenopausal Breast Cancer Survivors J. Clin. Oncol., May 15, 2003; 21(10): 1961 - 1966. [Abstract] [Full Text] [PDF]

				R. Kaaks, A. Lukanova, and M. S. Kurzer Obesity, Endogenous Hormones, and Endometrial Cancer Risk: A Synthetic Review Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1531 - 1543. [Abstract] [Full Text] [PDF]

				M. M. Buijs, J. A. Romijn, J. Burggraaf, M. L. de Kam, A. F. Cohen, M. Frolich, F. Stellaard, A. E. Meinders, and H. Pijl Growth Hormone Blunts Protein Oxidation and Promotes Protein Turnover to a Similar Extent in Abdominally Obese and Normal-Weight Women J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5668 - 5674. [Abstract] [Full Text] [PDF]

				G. E. Hale, C. L. Hughes, and J. M. Cline Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15. [Abstract] [Full Text] [PDF]

				H. YAMASAKI, T. DOUCHI, S. YAMAMOTO, T. OKI, R. KUWAHATA, and Y. NAGATA Body Fat Distribution and Body Composition During GnRH Agonist Therapy Obstet. Gynecol., March 1, 2001; 97(3): 338 - 342. [Abstract] [Full Text] [PDF]

				B. L. Wajchenberg Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome Endocr. Rev., December 1, 2000; 21(6): 697 - 738. [Abstract] [Full Text]

				T. DOUCHI, S. YAMAMOTO, R. KUWAHATA, T. OKI, H. YAMASAKI, and Y. NAGATA Effect of Non-Weight-Bearing Body Fat on Bone Mineral Density Before and After Menopause Obstet. Gynecol., July 1, 2000; 96(1): 13 - 17. [Abstract] [Full Text] [PDF]

				T. DOUCHI, S. YAMAMOTO, T. OKI, K. MARUTA, R. KUWAHATA, and Y. NAGATA Relationship Between Body Fat Distribution and Bone Mineral Density in Premenopausal Japanese Women Obstet. Gynecol., May 1, 2000; 95(5): 722 - 725. [Abstract] [Full Text] [PDF]

				T. DOUCHI, S. YAMAMOTO, T. OKI, K. MARUTA, R. KUWAHATA, and Y. NAGATA Serum Androgen Levels and Muscle Mass in Women With Polycystic Ovary Syndrome Obstet. Gynecol., September 1, 1999; 94(3): 337 - 340. [Abstract] [Full Text] [PDF]

				J. M. Schildkraut, W. Demark-Wahnefried, E. DeVoto, C. Hughes, J. L. Laseter, and B. Newman Environmental Contaminants and Body Fat Distribution Cancer Epidemiol. Biomarkers Prev., February 1, 1999; 8(2): 179 - 183. [Abstract] [Full Text]

				J. M. H. Elbers, H. Asscheman, J. C. Seidell, and L. J. G. Gooren Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E317 - E325. [Abstract] [Full Text] [PDF]

				A. M. Corbould, S. J. Judd, and R. J. Rodgers Expression of Types 1, 2, and 3 17{beta}-Hydroxysteroid Dehydrogenase in Subcutaneous Abdominal and Intra-Abdominal Adipose Tissue of Women J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 187 - 194. [Abstract] [Full Text]

				A. Solini, E. Bonora, R. Bonadonna, P. Castellino, and R. A. DeFronzo Protein Metabolism in Human Obesity: Relationship with Glucose and Lipid Metabolism and with Visceral Adipose Tissue J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2552 - 2558. [Abstract] [Full Text] [PDF]

				R. G. Ziegler Anthropometry and Breast Cancer J. Nutr., May 1, 1997; 127 (5): 924S - 924S. [Abstract] [Full Text] [PDF]

				G. B. Phillips, B. H. Pinkernell, and T.-Y. Jing Relationship Between Serum Sex Hormones and Coronary Artery Disease in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 695 - 701. [Abstract] [Full Text]

				E. Barrett-Connor Sex Differences in Coronary Heart Disease: Why Are Women So Superior? The 1995 Ancel Keys Lecture Circulation, January 7, 1997; 95(1): 252 - 264. [Full Text]